|
KDM6A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.573200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.245500E-04 |
| Normal-vs-Stage2 |
4.420400E-01 |
| Normal-vs-Stage3 |
2.524800E-01 |
| Normal-vs-Stage4 |
1.001640E-02 |
| Stage1-vs-Stage2 |
1.820980E-01 |
| Stage1-vs-Stage3 |
2.453600E-01 |
| Stage1-vs-Stage4 |
8.211000E-01 |
| Stage2-vs-Stage3 |
8.171600E-01 |
| Stage2-vs-Stage4 |
2.811600E-01 |
| Stage3-vs-Stage4 |
3.917600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.838500E-04 |
| Normal-vs-AfricanAmerican |
7.324800E-03 |
| Normal-vs-Asian |
2.048400E-01 |
| Caucasian-vs-AfricanAmerican |
9.450200E-01 |
| Caucasian-vs-Asian |
7.819000E-01 |
| AfricanAmerican-vs-Asian |
7.570800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.42568204306326E-12 |
| Normal-vs-Female |
1.226830E-01 |
| Male-vs-Female |
4.26319979318635E-10 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.016400E-01 |
| Normal-vs-Extreme_Weight |
1.56942999999243E-05 |
| Normal-vs-Obese |
1.258150E-02 |
| Normal-vs-Extreme_Obese |
3.857100E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.277800E-02 |
| Normal_Weight-vs-Obese |
5.868600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.324370E-01 |
| Extreme_Weight-vs-Obese |
5.935500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.144600E-01 |
| Obese-vs-Extreme_Obese |
4.071400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.756400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.464000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.380100E-04 |
| Normal-vs-Age(81-100Yrs) |
3.335900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.081000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.274500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.077700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.959600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.485000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.507200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.95883999999369E-05 |
| Normal-VS-Type2 PRCC |
5.640400E-03 |
| Normal-VS-KIRP CIMP |
7.206000E-01 |
| Normal-VS-Unclassified PRCC |
1.357020E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.028800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.782300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.638440E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.182100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.900800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.345400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.32900000010738E-07 |
| Normal-vs-N1 |
8.135400E-01 |
| Normal-vs-N2 |
4.870800E-01 |
| N0-vs-N1 |
4.306400E-02 |
| N0-vs-N2 |
4.448000E-01 |
| N1-vs-N2 |
7.973400E-01 |
|
|
